Sherry Ferguson, PhD - Publications
Affiliations: | Neurotoxicology | National Center for Toxicologicsl Research/ FDA |
Year | Citation | Score | |||
---|---|---|---|---|---|
2021 | Ferguson SA, Panos JJ, Sloper D, Varma V, Sarkar S. Alzheimer's disease: a step closer to understanding type 3 diabetes in African Americans. Metabolic Brain Disease. PMID 34021875 DOI: 10.1007/s11011-021-00754-z | 0.605 | |||
2019 | Ferguson SA, Varma V, Sloper D, Panos JJ, Sarkar S. Increased inflammation in BA21 brain tissue from African Americans with Alzheimer's disease. Metabolic Brain Disease. PMID 31823110 DOI: 10.1007/s11011-019-00512-2 | 0.603 | |||
2017 | Ferguson SA, Panos JJ, Sloper D, Varma V. Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 28582866 DOI: 10.3233/JAD-170204 | 0.601 | |||
2016 | Ferguson SA, Panos J, Sloper DT, Varma V. P1-330: Altered Levels of ABETA42 in BA21 Brain Region of African Americans Relative to Caucasians with Alzheimer's Disease Alzheimer's & Dementia. 12: P554-P555. DOI: 10.1016/j.jalz.2016.06.1081 | 0.597 | |||
2015 | Ferguson SA, Law CD, Sarkar S. Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatment. Behavioural Brain Research. 292: 68-78. PMID 26111725 DOI: 10.1016/J.Ntt.2015.04.104 | 0.313 | |||
2014 | Panos JJ, O'Callaghan JP, Miller DB, Ferguson SA. Effects of developmental methylphenidate (MPH) treatment on monoamine neurochemistry of male and female rats. Neurotoxicology and Teratology. 45: 70-4. PMID 25132048 DOI: 10.1016/j.ntt.2014.08.001 | 0.589 | |||
2014 | Panos JJ, Law CD, Ferguson SA. Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague-Dawley offspring. Neurotoxicology and Teratology. 42: 9-16. PMID 24444667 DOI: 10.1016/j.ntt.2014.01.004 | 0.588 | |||
Show low-probability matches. |